EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Texture analysis of 18F‐FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement

Elisabetta M Abenavoli iD, Flavia Linguanti, Matilde Anichini, Vittorio Miele, Francesco Mungai, Marianna Palazzo, Luca Nassi, Benedetta Puccini, Ilaria Romano, Benedetta Sordi, Roberto Sciagrà, Gabriele Simontacchi und 2 weitere

Hematological Oncology · 2024

DOI: 10.1002/hon.3261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2024. Verfasst von Elisabetta M Abenavoli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Hodgkin Disease, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To recognize patients at high risk of refractory disease, the identification of novel prognostic parameters improving stratification of newly diagnosed Hodgkin Lymphoma (HL) is still needed. This study investigates the potential value of metabolic and texture features, extracted from baseline 18F‐FDG Positron Emission Tomography/Computed Tomography (PET) and Contrast‐Enhanced Computed Tomography scan (CECT), together with clinical data, in predicting first‐line therapy refractoriness (R) of classical HL (cHL) with mediastinal bulk involvement. We reviewed 69 cHL patients who underwent staging PET and CECT. Lesion segmentation and texture parameter extraction were performed using the freeware software LIFEx 6.3. The prognostic significance of clinical and imaging features was evaluated in relation to the development of refractory disease. Receiver operating characteristic curve, Cox proportional hazard regression and Kaplan‐Meier analyses were performed to examine the potential independent predictors and to evaluate their prognostic value. Among clinical characteristics, only stage according to the German Hodgkin Group (GHSG) classification system significantly differed between R and not‐R. Among CECT variables, only parameters derived from second order matrices (gray‐level co‐occurrence matrix (GLCM) and gray‐level run length matrix (GLRLM) demonstrated significant prognostic power. Among PET variables, SUVmean, several variables derived from first (histograms, shape), and second order analyses (GLCM, GLRLM, NGLDM) exhibited significant predictive power. Such variables obtained accuracies greater than 70% at receiver operating characteristic analysis and their PFS curves resulted statistically significant in predicting refractoriness. At multivariate analysis, only HISTO_EntropyPET extracted from PET (HISTO_Entropy PET ) and GHSG stage resulted as significant independent predictors. Their combination identified 4 patient groups with significantly different PFS curves, with worst prognosis in patients with higher HISTO_Entropy PET values, regardless of the stage. Imaging radiomics may provide a reference for prognostic evaluation of patients with mediastinal bulky cHL. The best prognostic value in the prediction of R versus not‐R disease was reached by combining HISTO_Entropy PET with GHSG stage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseasePositron Emission Tomography Computed TomographyHumansFluorodeoxyglucose F18Positron-Emission TomographyPrognosisRetrospective Studies

Stichwörter der Autor:innen

Hodgkin lymphomaPETbulkyrefractory diseasetextural analysis

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Nuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.
  • Department of Radiology, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Hematology Department, University of Florence and Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

ORCID-Profile: Elisabetta M Abenavoli

Zitieren

APA

Abenavoli, E. M., Linguanti, F., Anichini, M., Miele, V., Mungai, F., Palazzo, M., Nassi, L., Puccini, B., Romano, I., Sordi, B., Sciagrà, R., Simontacchi, G., Vannucchi, A. M., & Berti, V. (2024). Texture analysis of 18F‐FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement. Hematological Oncology. https://doi.org/10.1002/hon.3261

Vancouver

Abenavoli EM, Linguanti F, Anichini M, Miele V, Mungai F, Palazzo M, et al. Texture analysis of 18F‐FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement. Hematological Oncology. 2024. doi:10.1002/hon.3261

BibTeX
@article{Abenavoli2024,
  author = {Abenavoli, Elisabetta M and Linguanti, Flavia and Anichini, Matilde and Miele, Vittorio and Mungai, Francesco and Palazzo, Marianna and Nassi, Luca and Puccini, Benedetta and Romano, Ilaria and Sordi, Benedetta and Sciagrà, Roberto and Simontacchi, Gabriele and Vannucchi, Alessandro M and Berti, Valentina},
  title = {Texture analysis of 18F‐FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement},
  journal = {Hematological Oncology},
  year = {2024},
  doi = {10.1002/hon.3261}
}
Kostenlos starten →